(Q45635055)

14 December 2017

title

cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing (English)

1 reference

equine infectious anemia virus

14 December 2017

main subject

equine infectious anemia

1 reference

based on heuristic

inferred from title

object named as

equine infectious anemia virus

1 reference

Huey-Jane Liao

1

1 reference

14 December 2017

Carl C Baker

series ordinal

2

1 reference

14 December 2017

Gerald L Princler

series ordinal

3

1 reference

14 December 2017

David Derse

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

14 December 2017

1 reference

14 December 2017

volume

323

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

131-140

1 reference

Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Sorting out the complexity of SR protein functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

RNA export: insights from viral models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Control of Alternative Splicing by the Differential Binding of U1 Small Nuclear Ribonucleoprotein Particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Finding signals that regulate alternative splicing in the post-genomic era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Alternative splicing of SV40 early pre-mRNA is determined by branch site selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Intron sequences involved in lariat formation during pre-mRNA splicing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

The role of the mammalian branchpoint sequence in pre-mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Determinants of SR protein specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Precise branch point mapping and quantification of splicing intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Functional recognition of the 3' splice site AG by the splicing factor U2AF35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

SR proteins: a conserved family of pre-mRNA splicing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Cloning and domain structure of the mammalian splicing factor U2AF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

A compensatory base change in human U2 snRNA can suppress a branch site mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Both subunits of U2AF recognize the 3' splice site in Caenorhabditis elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.12.028

1 reference

14 December 2017

1 reference